"This year, every industry will become a technology industry," NVIDIA founder and CEO Jensen Huang told attendees last Wednesday during the annual J.P. Morgan Healthcare Conference. "You can now recognize and learn the language of almost anything with structure, and you can translate it to anything with structure—so text-protein, protein-text," Huang said in a fireside chat with Martin Chavez, partner and vice chairman of global investment firm Sixth Street Partners and board chair of Recursion, a biopharmaceutical company. "This is the generative AI revolution."

The conversation, which took place at the historic San Francisco Mint, followed a presentation at the J.P. Morgan conference Monday by Kimberly Powell, NVIDIA's VP of healthcare. In her talk, Powell announced that Recursion is the first hosting partner to offer a foundation model through the NVIDIA BioNeMo cloud service, which is advancing into beta this month. She also said that Amgen, one of the first companies to employ BioNeMo, plans to advance drug discovery with generative AI and NVIDIA DGX SuperPOD—and that BioNeMo is used by a growing number of techbio companies, pharmas, AI software vendors and systems integrators. Among them are Deloitte, Innophore, Insilico Medicine, OneAngstrom, Recursion and Terray Therapeutics.

Scientific researchers need massive computational resources that can support exploration wherever it happens. Whether they're conducting groundbreaking pharmaceutical research, exploring alternative energy sources or discovering new ways to prevent financial fraud, accessible state-of-the-art AI computing resources are key to driving innovation. This new model of computing can solve the challenges of generative AI and power the next wave of innovation. Cambridge-1, a supercomputer NVIDIA launched in the U.K. during the pandemic, has powered discoveries from some of the country's top healthcare researchers. The system is now becoming part of NVIDIA DGX Cloud to accelerate the pace of scientific innovation and discovery - across almost every industry.

As a cloud-based resource, it will broaden access to AI supercomputing for researchers in climate science, autonomous machines, worker safety and other areas, delivered with the simplicity and speed of the cloud, ideally located for the U.K. and European access. DGX Cloud is a multinode AI training service that makes it possible for any enterprise to access leading-edge supercomputing resources from a browser. The original Cambridge-1 infrastructure included 80 NVIDIA DGX systems; now it will join with DGX Cloud, to allow customers access to world-class infrastructure.